Someone else says freezing is okay
"So, when people come off a medication that they need to treat a chronic condition -- which the conditions of overweight and obesity are -- of course, rebound weight gain is possible, if not likely." In the United States, obesity affects nearly 42% of the population and is associated with over $170 billion in medical costs, according to the Centers for Disease Control and Prevention
But unlike brand-name GLP-1s, they arent Food and Drug Administration approved
Many insurance companies are pulling back on GLP-1 coverage Meanwhile, many insurers, including some state Medicaid programs, are limiting or even dropping coverage for weight-loss drugs because of cost
The study established the ~6-day half-life and confirmed once-weekly dosing feasibility
it cannot be legally prescribed or supplied as a standard treatment in the UK